GFM
ACIU icon

GF Fund Management’s AC Immune ACIU Stock Holding History

GF Fund Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.96K Sell
2,084
-158
-7% -$435 ﹤0.01% 572
2026
Q1 		$6.17K Buy
2,242
+270
+14% +$838 ﹤0.01% 594
2025
Q4 		$6.19K Sell
1,972
-188
-9% -$593 ﹤0.01% 611
2025
Q3 		$6.24K Sell
2,160
-294
-12% -$664 ﹤0.01% 595
2025
Q2 		$4.98K Hold
2,454
– – ﹤0.01% 625
2025
Q1 		$4.59K Buy
2,454
+377
+18% +$950 ﹤0.01% 627
2024
Q4 		$5.61K Buy
+2,077
New +$6.49K ﹤0.01% 604

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GF Fund Management's ACIU Position: Q2 2026 in Review

GF Fund Management reduced its AC Immune (ACIU) stake by 7% in Q2 2026, selling an estimated $435 and leaving 2,084 shares worth $4.96K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

GF Fund Management first reported a position in ACIU in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.24K in Q3 2025. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • GF Fund Management held 2,084 shares of AC Immune worth $4.96K as of Q2 2026.
  • GF Fund Management sold 158 AC Immune shares in Q2 2026, an estimated $435.
  • AC Immune made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #572 holding.
  • GF Fund Management first reported a position in AC Immune in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's AC Immune position peaked at $6.24K in Q3 2025.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.